These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 32210942)

  • 1. Bacteriophage Protects Against
    Xi H; He D; Li D; Liu SS; Wang G; Ji Y; Wang X; Wang Z; Bi L; Zhao R; Zhang H; Yang L; Guo Z; Han W; Gu J
    Front Vet Sci; 2020; 7():588. PubMed ID: 33005648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant
    Bao J; Wu N; Zeng Y; Chen L; Li L; Yang L; Zhang Y; Guo M; Li L; Li J; Tan D; Cheng M; Gu J; Qin J; Liu J; Li S; Pan G; Jin X; Yao B; Guo X; Zhu T; Le S
    Emerg Microbes Infect; 2020 Dec; 9(1):771-774. PubMed ID: 32212918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.
    Steele A; Stacey HJ; de Soir S; Jones JD
    Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33138253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization, Antibiofilm, and Depolymerizing Activity of Two Phages Active on Carbapenem-Resistant
    Vukotic G; Obradovic M; Novovic K; Di Luca M; Jovcic B; Fira D; Neve H; Kojic M; McAuliffe O
    Front Med (Lausanne); 2020; 7():426. PubMed ID: 32974360
    [No Abstract]   [Full Text] [Related]  

  • 5. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Efficacy of Phage P
    Wang X; Ji Y; Su J; Xue Y; Xi H; Wang Z; Bi L; Zhao R; Zhang H; Yang L; Guo Z; Guan Y; Feng X; Sun C; Lei L; Ur Rahman S; Dong J; Han W; Gu J
    Appl Environ Microbiol; 2020 Oct; 86(22):. PubMed ID: 32887718
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriophage Therapy as an Application for Bacterial Infection in China.
    Liang S; Qi Y; Yu H; Sun W; Raza SHA; Alkhorayef N; Alkhalil SS; Salama EEA; Zhang L
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanism of Important Components in Canine Fecal Microbiota Transplantation.
    Li K; Yang J; Zhou X; Wang H; Ren Y; Huang Y; Liu H; Zhong Z; Peng G; Zheng C; Zhou Z
    Vet Sci; 2022 Dec; 9(12):. PubMed ID: 36548856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly different effects of phage therapy and antibiotic therapy on immunological responses of chickens infected with
    Grabowski Ł; Węgrzyn G; Węgrzyn A; Podlacha M
    Front Immunol; 2022; 13():956833. PubMed ID: 36211337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bacteriophage vB_CbrM_HP1 Protects Crucian Carp Against
    Huang C; Feng C; Liu X; Zhao R; Wang Z; Xi H; Ou H; Han W; Guo Z; Gu J; Zhang L
    Front Vet Sci; 2022; 9():888561. PubMed ID: 35601403
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacteriophage therapy in aquaculture: current status and future challenges.
    Liu R; Han G; Li Z; Cun S; Hao B; Zhang J; Liu X
    Folia Microbiol (Praha); 2022 Aug; 67(4):573-590. PubMed ID: 35305247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of Two Broad Host Range Phages of
    Hammerl JA; Barac A; Erben P; Fuhrmann J; Gadicherla A; Kumsteller F; Lauckner A; Müller F; Hertwig S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768812
    [No Abstract]   [Full Text] [Related]  

  • 13. vB-ApyS-JF1, the First
    Ji Y; Song L; Zhou Z; Liu X; Li F; Guo Z; Guan Y; Yang L; Feng X; Sun C; Lei L; Han W; Gu J
    Front Microbiol; 2021; 12():736304. PubMed ID: 34759899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of Bacteriophages with Animal and Human Organisms-Safety Issues in the Light of Phage Therapy.
    Podlacha M; Grabowski Ł; Kosznik-Kawśnicka K; Zdrojewska K; Stasiłojć M; Węgrzyn G; Węgrzyn A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic, Morphological and Functional Characterization of Virulent Bacteriophage IME-JL8 Targeting
    Jia K; Yang N; Zhang X; Cai R; Zhang Y; Tian J; Raza SHA; Kang Y; Qian A; Li Y; Sun W; Shen J; Yao J; Shan X; Zhang L; Wang G
    Front Microbiol; 2020; 11():585261. PubMed ID: 33329451
    [No Abstract]   [Full Text] [Related]  

  • 16. The Yersinia Phage X1 Administered Orally Efficiently Protects a Murine Chronic Enteritis Model Against
    Xue Y; Zhai S; Wang Z; Ji Y; Wang G; Wang T; Wang X; Xi H; Cai R; Zhao R; Zhang H; Bi L; Guan Y; Guo Z; Han W; Gu J
    Front Microbiol; 2020; 11():351. PubMed ID: 32210942
    [No Abstract]   [Full Text] [Related]  

  • 17. The Podovirus ϕ80-18 Targets the Pathogenic American Biotype 1B Strains of
    Filik K; Szermer-Olearnik B; Wernecki M; Happonen LJ; Pajunen MI; Nawaz A; Qasim MS; Jun JW; Mattinen L; Skurnik M; Brzozowska E
    Front Microbiol; 2020; 11():1356. PubMed ID: 32636826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.
    Heesemann J; Gaede K; Autenrieth IB
    APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.